DAF
0.016
60%
ATC
0.001
-50%
FAU
0.009
50%
ARV
0.003
-25%
M2M
0.009
50%
CHM
0.015
-25%
DXN
0.39
41.8%
EPN
0.022
-24.1%
NXL
1.915
34.4%
RWL
0.15
-21.1%
ARO
0.004
33.3%
ERE
0.012
-20%
C7A
0.004
33.3%
FIN
0.004
-20%
RKB
0.004
33.3%
KGN
3.67
-18.6%
ABE
0.027
28.6%
IRD
0.009
-18.2%
AUQ
0.047
27%
SP3
0.009
-18.2%
PKY
0.043
26.5%
CDE
0.005
-16.7%
ACU
0.13
23.8%
ENL
0.005
-16.7%
AXN
0.033
22.2%
RLG
0.005
-16.7%
COY
0.006
20%
WIN
0.015
-16.7%
ECS
0.006
20%
ALM
0.011
-15.4%
ESR
0.036
20%
AEV
0.006
-14.3%
GTN
0.24
20%
CRR
0.006
-14.3%
RGL
0.012
20%
UNT
0.006
-14.3%
WRX
0.024
20%
HMG
0.225
-13.5%
ZEU
0.006
20%
NPM
0.013
-13.3%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Arovella Therapeutics (ASX:ALA): TSN -The Stock Network

November 2023: Arovella Therapeutics (ASX:ALA) CEO & Managing Director Michael Baker presents for The Stock Network
.
Learn more about Arovella Therapeutics: https://www.arovella.com/